Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Imago Systems, Inc. provides the Visual Intelligence® platform and Imago ICE Reveal™ software for medical imaging, positioned as a cloud-based Medical Software as a Service (MSaaS). Its core idea is not to replace a hospital’s existing imaging equipment, but to apply algorithmic post-processing to raw medical images, visualize and characterize image content, and, according to the company, reveal abnormal information as small as 1mm.
Based on information on the official website, the platform focuses on detection, monitoring, and assessment of treatment-effect information in medical imaging. It can convert unstructured imaging data into structured imaging data, making patterns such as grayscale variations and dense white areas more quantifiable. Use cases include early cancer screening, differentiation between COVID and pneumonia presentations, and analysis of cardiovascular arterial plaque/occlusion.
For integration, Imago emphasizes seamless compatibility with existing DICOM and HIPAA-compliant medical imaging protocols. It also plans to pursue partnerships or licensing with device manufacturers, radiology groups, CROs, and AI/machine learning analytics companies.
The official website does not disclose a specific price list or plan tiers, but it describes four commercialization models: per-scan subscription pricing, licensing and recurring royalties for devices or systems, per-scan fees for image uploads through the Visual Intelligence® portal, and R&D/custom development partnerships. This model is more oriented toward B2B/B2B2H healthcare ecosystem partnerships, rather than self-service purchasing like a general-purpose SaaS product.
The main advantage is that it does not require replacing traditional imaging equipment, which in theory lowers the adoption barrier for hospitals. Its design around DICOM, HIPAA, and near-real-time cloud processing also fits medical imaging workflows. The team and advisors cover medical imaging, cardiovascular medicine, radiology, regulation, and medical device commercialization.
The limitations are also clear: the website lacks key information such as a free trial, API details, permission management, audit capabilities, data residency, implementation timelines, and real customer case studies. Actual adoption of medical software may also be affected by regulatory approvals, clinical validation, and integration with hospital systems.
It is better suited for imaging equipment manufacturers, medical imaging centers, radiology groups, CROs, insurers, and medical AI companies evaluating partnerships, rather than ordinary business users. The official website does not specify access or payment availability from China, so this remains unknown. Domestic alternatives or comparable vendors in China include InferVision and Deepwise, while international solutions to watch include Aidoc, Viz.ai, and Arterys.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on imagosystems.com official site.
imagosystems.com is an United States AI Apps provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach imagosystems.com directly.